>
SpaceX Acquires Cursor AI In $60 Billion Deal As Coding Agent Race Heats Up
From Hormuz To Houston: The US Takeover Of Global Energy Flows Ramps Up
US Housing Starts Collapsed In May To Lowest Since COVID
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap

As we have explored in previous writings, cancer stem cells have been identified to be at the heart of most cancer malignancies. These extraordinarily resilient and proliferative cells, while only making up a minority of cells within a tumor (about 1 in 1,000), are relatively immortal and resistant to conventional treatments.
In fact, chemotherapy and radiation treatments have been found to increase the cancer stem cell populations by number and by their malignant/invasive intensity. In fact, radiotherapy has even been found to convert non-malignant breast cells into highly malignant breast cancer stem cells, resulting in increasing their malignancy by 30 fold. The use of these inappropriate treatments has resulted in an epidemic of iatrogenically caused secondary cancers, and patient deaths, that have largely gone unreported by the very medical system responsible for causing them, and which comes to no surprise by those who have been following our decade long reporting on the tragedy of cancer overdiagnosis and overtreatment, which has affected millions around the world.